These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 19903320)

  • 1. Detecting autologous blood transfusions: a comparison of three passport approaches and four blood markers.
    Mørkeberg J; Sharpe K; Belhage B; Damsgaard R; Schmidt W; Prommer N; Gore CJ; Ashenden MJ
    Scand J Med Sci Sports; 2011 Apr; 21(2):235-43. PubMed ID: 19903320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of autologous blood transfusions in athletes: a historical perspective.
    Mørkeberg J
    Transfus Med Rev; 2012 Jul; 26(3):199-208. PubMed ID: 22119492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemoglobin mass and biological passport for the detection of autologous blood doping.
    Pottgiesser T; Echteler T; Sottas PE; Umhau M; Schumacher YO
    Med Sci Sports Exerc; 2012 May; 44(5):835-43. PubMed ID: 21988933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of autologous blood doping with adaptively evaluated biomarkers of doping: a longitudinal blinded study.
    Pottgiesser T; Sottas PE; Echteler T; Robinson N; Umhau M; Schumacher YO
    Transfusion; 2011 Aug; 51(8):1707-15. PubMed ID: 21382045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for autologous blood transfusions.
    Mørkeberg J; Belhage B; Ashenden M; Bornø A; Sharpe K; Dziegiel MH; Damsgaard R
    Int J Sports Med; 2009 Apr; 30(4):285-92. PubMed ID: 19199200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hb mass measurement suitable to screen for illicit autologous blood transfusions.
    Pottgiesser T; Umhau M; Ahlgrim C; Ruthardt S; Roecker K; Schumacher YO
    Med Sci Sports Exerc; 2007 Oct; 39(10):1748-56. PubMed ID: 17909402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reticulocyte and haemoglobin profiles in elite triathletes over four consecutive seasons.
    Díaz V; Lombardi G; Ricci C; Jacobs RA; Montalvo Z; Lundby C; Banfi G
    Int J Lab Hematol; 2011 Dec; 33(6):638-44. PubMed ID: 21707935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detecting doping use: more than an analytical problem.
    Delanghe JR; Maenhout TM; Speeckaert MM; De Buyzere ML
    Acta Clin Belg; 2014; 69(1):25-9. PubMed ID: 24635395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Within-subject variation in hemoglobin mass in elite athletes.
    Eastwood A; Sharpe K; Bourdon PC; Woolford SM; Saunders PU; Robertson EY; Clark SA; Gore CJ
    Med Sci Sports Exerc; 2012 Apr; 44(4):725-32. PubMed ID: 21952636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current strategic approaches for the detection of blood doping practices.
    Segura J; Ventura R; Pascual JA
    Forensic Sci Int; 2011 Dec; 213(1-3):42-8. PubMed ID: 21889274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection methods for autologous blood doping.
    Segura J; Monfort N; Ventura R
    Drug Test Anal; 2012 Nov; 4(11):876-81. PubMed ID: 22407819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-transfusion stability of haemoglobin mass.
    Pottgiesser T; Specker W; Umhau M; Roecker K; Schumacher YO
    Vox Sang; 2009 Feb; 96(2):119-27. PubMed ID: 19152604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total hemoglobin mass--a new parameter to detect blood doping?
    Prommer N; Sottas PE; Schoch C; Schumacher YO; Schmidt W
    Med Sci Sports Exerc; 2008 Dec; 40(12):2112-8. PubMed ID: 18981937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in hemoglobin profile reflect autologous blood transfusion misuse in sports.
    Lamberti N; Finotti A; Gasparello J; Lampronti I; Zambon C; Cosenza LC; Fabbri E; Bianchi N; Dalla Corte F; Govoni M; Reverberi R; Gambari R; Manfredini F
    Intern Emerg Med; 2018 Jun; 13(4):517-526. PubMed ID: 29572786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of autologous blood transfusions in cross-country skiers.
    Berglund B; Hemmingsson P; Birgegård G
    Int J Sports Med; 1987 Apr; 8(2):66-70. PubMed ID: 3596878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of blood withdrawal and reinfusion on biomarkers of erythropoiesis in humans: Implications for anti-doping strategies.
    Damsgaard R; Munch T; Mørkeberg J; Mortensen SP; González-Alonso J
    Haematologica; 2006 Jul; 91(7):1006-8. PubMed ID: 16584989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for recombinant human erythropoietin using [Hb], reticulocytes, the OFF(hr score), OFF(z score) and Hb(z score): status of the Blood Passport.
    Bornø A; Aachmann-Andersen NJ; Munch-Andersen T; Hulston CJ; Lundby C
    Eur J Appl Physiol; 2010 Jun; 109(3):537-43. PubMed ID: 20127125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recombinant erythropoietin in autologous blood donation].
    von Bormann B; Weidler B; Friedrich M; von Andrian-Werburg H
    Anaesthesist; 1991 Jul; 40(7):386-90. PubMed ID: 1928712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of low-volume blood withdrawal on hematological biomarkers for the athlete biological passport.
    Krumm B; Saugy JJ; Botrè F; Faiss R
    Drug Test Anal; 2024 Feb; 16(2):168-173. PubMed ID: 37303297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Transfusion of recuperated blood in total knee arthroplasty].
    Pitsaer E
    Rev Chir Orthop Reparatrice Appar Mot; 2002 Dec; 88(8):777-89. PubMed ID: 12503019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.